LT2918286T - Farmacinis preparatas, kurio sudėtyje yra kristalinės ir taip pat ištirpintos formos insulino - Google Patents

Farmacinis preparatas, kurio sudėtyje yra kristalinės ir taip pat ištirpintos formos insulino

Info

Publication number: LT2918286T
Authority: LT; Lithuania
Prior art keywords: crystalline; well; pharmaceutical preparation; preparation containing; containing insulin
Prior art date: 2004-10-05

Application number

LTEP15161696.8T

Other languages

English (en)

Inventor

Petter Berglund

Charlotte Hammelev

Lone Eskildsen

Johanne Madsen

Helle Aalund Olsen

Lone Logstrup Kimer

Original Assignee

Novo Nordisk A/S

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-10-05

Filing date

2005-10-05

Publication date

2020-04-10

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35428106&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT2918286(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-10-05 Application filed by Novo Nordisk A/S filed Critical Novo Nordisk A/S

2020-04-10 Publication of LT2918286T publication Critical patent/LT2918286T/lt

Links

NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title 2
102000004877 Insulin Human genes 0.000 title 1
108090001061 Insulin Proteins 0.000 title 1
229940125396 insulin Drugs 0.000 title 1
239000000825 pharmaceutical preparation Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Diabetes (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Endocrinology (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Obesity (AREA)
Hematology (AREA)
Organic Chemistry (AREA)
Emergency Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Peptides Or Proteins (AREA)

LTEP15161696.8T 2004-10-05 2005-10-05 Farmacinis preparatas, kurio sudėtyje yra kristalinės ir taip pat ištirpintos formos insulino LT2918286T (lt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DKPA200401519		2004-10-05

Publications (1)

Publication Number	Publication Date
LT2918286T true LT2918286T (lt)	2020-04-10

Family

ID=35428106

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LTEP15161696.8T LT2918286T (lt)	2004-10-05	2005-10-05	Farmacinis preparatas, kurio sudėtyje yra kristalinės ir taip pat ištirpintos formos insulino

Country Status (19)

Country	Link
US (1)	US7884181B2 (lt)
EP (4)	EP2926828B1 (lt)
JP (1)	JP5080259B2 (lt)
KR (1)	KR101238184B1 (lt)
CN (2)	CN102772788B (lt)
AU (1)	AU2005291233B2 (lt)
BR (1)	BRPI0516464B8 (lt)
CA (1)	CA2581798A1 (lt)
CY (1)	CY1124650T1 (lt)
DK (1)	DK2918286T3 (lt)
ES (3)	ES2779957T3 (lt)
HU (1)	HUE048806T2 (lt)
LT (1)	LT2918286T (lt)
MX (1)	MX2007003897A (lt)
PL (2)	PL1802329T3 (lt)
PT (1)	PT2918286T (lt)
RU (1)	RU2389503C2 (lt)
SI (1)	SI2918286T1 (lt)
WO (1)	WO2006037789A1 (lt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2008065138A1 (en) *	2006-11-29	2008-06-05	Novo Nordisk A/S	Novel insulin crystal and method for preparing the crystal
CN102219851B (zh) *	2011-05-09	2012-05-30	甘李药业有限公司	甘精胰岛素结晶的制备方法
BR112015013223A2 (pt) *	2012-12-26	2017-07-11	Wockhardt Ltd	composição farmacêutica
CN112957455A (zh)	2014-01-09	2021-06-15	赛诺菲	胰岛素类似物和/或胰岛素衍生物的稳定化药物制剂
RU2014120626A (ru) *	2014-05-22	2015-11-27	Владимир Андреевич Сабецкий	Инсулинсодержащий препарат пролонгированного действия
CN105535942B (zh) *	2016-01-28	2017-07-28	通化东宝药业股份有限公司	一种赖脯胰岛素硫酸鱼精蛋白制剂的制备方法及其制备的赖脯胰岛素硫酸鱼精蛋白制剂
WO2017163159A1 (en) *	2016-03-21	2017-09-28	Wockhardt Limited	Biphasic pharmaceutical composition of insulin human
CN113248591B (zh) *	2021-07-08	2021-09-28	北京惠之衡生物科技有限公司	一种门冬胰岛素结晶工艺
CN113384529B (zh) *	2021-07-08	2021-11-26	北京惠之衡生物科技有限公司	一种门冬胰岛素注射液及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB889769A (en) *	1957-07-18	1962-02-21	Nordisk Insulinlab	Slowly acting insulin preparation in crystalline form
DK72793D0 (da) *	1993-06-21	1993-06-21	Novo Nordisk As	Nyt produkt
US5461031A (en)	1994-06-16	1995-10-24	Eli Lilly And Company	Monomeric insulin analog formulations
US5474978A (en)	1994-06-16	1995-12-12	Eli Lilly And Company	Insulin analog formulations
ATE369146T1 (de)	1996-06-20	2007-08-15	Novo Nordisk As	Insulinpreparation mit mannitol
US5866538A (en)	1996-06-20	1999-02-02	Novo Nordisk A/S	Insulin preparations containing NaCl
US5948751A (en)	1996-06-20	1999-09-07	Novo Nordisk A/S	X14-mannitol
DK0921812T4 (da)	1996-06-20	2012-04-02	Novo Nordisk As	Insulinpræparater, som indeholder et halogenid
CZ2004710A3 (cs) *	2001-12-20	2005-02-16	Eli Lilly And Company	Inzulínová sloučenina s protrahovaným účinkem
WO2004080481A1 (en) *	2003-03-13	2004-09-23	Novo Nordisk A/S	Novel nph insulin preparations

2005
- 2005-10-05 AU AU2005291233A patent/AU2005291233B2/en not_active Ceased
- 2005-10-05 PL PL05792052T patent/PL1802329T3/pl unknown
- 2005-10-05 EP EP15160523.5A patent/EP2926828B1/en not_active Expired - Lifetime
- 2005-10-05 EP EP15161696.8A patent/EP2918286B1/en not_active Expired - Lifetime
- 2005-10-05 JP JP2007535163A patent/JP5080259B2/ja not_active Expired - Fee Related
- 2005-10-05 PL PL15161696T patent/PL2918286T3/pl unknown
- 2005-10-05 ES ES15161696T patent/ES2779957T3/es not_active Expired - Lifetime
- 2005-10-05 LT LTEP15161696.8T patent/LT2918286T/lt unknown
- 2005-10-05 PT PT151616968T patent/PT2918286T/pt unknown
- 2005-10-05 US US11/664,407 patent/US7884181B2/en active Active - Reinstated
- 2005-10-05 HU HUE15161696A patent/HUE048806T2/hu unknown
- 2005-10-05 MX MX2007003897A patent/MX2007003897A/es active IP Right Grant
- 2005-10-05 KR KR1020077007794A patent/KR101238184B1/ko not_active Expired - Fee Related
- 2005-10-05 WO PCT/EP2005/055017 patent/WO2006037789A1/en not_active Ceased
- 2005-10-05 DK DK15161696.8T patent/DK2918286T3/da active
- 2005-10-05 CN CN201210248925.9A patent/CN102772788B/zh not_active Expired - Fee Related
- 2005-10-05 RU RU2007111879/15A patent/RU2389503C2/ru active
- 2005-10-05 BR BRPI0516464A patent/BRPI0516464B8/pt not_active IP Right Cessation
- 2005-10-05 CA CA002581798A patent/CA2581798A1/en not_active Withdrawn
- 2005-10-05 ES ES05792052.2T patent/ES2544329T3/es not_active Expired - Lifetime
- 2005-10-05 CN CN2005800339452A patent/CN101035557B/zh not_active Expired - Fee Related
- 2005-10-05 EP EP20158951.2A patent/EP3689366A1/en not_active Withdrawn
- 2005-10-05 SI SI200532272T patent/SI2918286T1/sl unknown
- 2005-10-05 EP EP20050792052 patent/EP1802329B1/en not_active Expired - Lifetime
- 2005-10-05 ES ES15160523T patent/ES2774354T3/es not_active Expired - Lifetime
2020
- 2020-03-23 CY CY20201100270T patent/CY1124650T1/el unknown

Also Published As

Publication number	Publication date
CN102772788A (zh)	2012-11-14
CN102772788B (zh)	2017-06-06
ES2544329T3 (es)	2015-08-28
EP2926828A1 (en)	2015-10-07
AU2005291233B2 (en)	2011-02-03
CY1124650T1 (el)	2022-03-24
EP3689366A1 (en)	2020-08-05
EP2918286A1 (en)	2015-09-16
CN101035557B (zh)	2012-09-05
HUE048806T2 (hu)	2020-08-28
PL2918286T3 (pl)	2020-06-29
BRPI0516464B8 (pt)	2021-05-25
DK2918286T3 (da)	2020-03-30
JP5080259B2 (ja)	2012-11-21
SI2918286T1 (sl)	2020-06-30
RU2007111879A (ru)	2008-11-20
CA2581798A1 (en)	2006-04-13
KR20070100874A (ko)	2007-10-12
PT2918286T (pt)	2020-03-27
EP1802329B1 (en)	2015-05-06
BRPI0516464A (pt)	2008-09-09
BRPI0516464B1 (pt)	2016-11-08
EP2926828B1 (en)	2019-12-11
MX2007003897A (es)	2007-05-21
AU2005291233A1 (en)	2006-04-13
EP2918286B1 (en)	2020-03-18
ES2774354T3 (es)	2020-07-20
KR101238184B1 (ko)	2013-03-04
CN101035557A (zh)	2007-09-12
JP2008515853A (ja)	2008-05-15
RU2389503C2 (ru)	2010-05-20
US7884181B2 (en)	2011-02-08
EP1802329A1 (en)	2007-07-04
WO2006037789A1 (en)	2006-04-13
ES2779957T3 (es)	2020-08-20
US20080171694A1 (en)	2008-07-17
PL1802329T3 (pl)	2015-10-30

Publication	Publication Date	Title
ZA200506941B (en)	2006-05-31	Improvements in or relating to drive mechanisms suitable for use in drug delivery devices
IL247788A0 (en)	2016-11-30	Conjugated medicinal composition
GB0310300D0 (en)	2003-06-11	Nanocomposite drug delivery composition
ZA200700632B (en)	2008-06-25	Non-skin penetrating reconstituting syringe
IL177480A0 (en)	2006-12-10	Pharmaceutical composition
GB0300427D0 (en)	2003-02-05	Pharmaceutical composition
IL173527A0 (en)	2006-07-05	Pharmaceutical composition containing water soluble drug
IL183929A0 (en)	2008-12-29	Use of inerferon - ?? in the preparation of a medicament
IL179933A0 (en)	2007-05-15	Pharmaceutical compositions containing proteosome based compositions
EP1757273A4 (en)	2011-02-09	PREPARATION FOR ORAL ADMINISTRATION
EP1731183A4 (en)	2011-07-06	SOLID PHARMACEUTICAL PREPARATION FOR DIALYSIS
EP1699458A4 (en)	2012-04-25	PHARMACEUTICAL COMPOSITION
SI1592457T1 (sl)	2012-12-31	Konjugat folat-vinblastin kot zdravilo
HUE048806T2 (hu)	2020-08-28	Inzulin kristályos, valamint szolubilizált formáját tartalmazó gyógyászati készítmény
IL166114A0 (en)	2006-01-15	Long-acting controlled-release pharmaceutical preparation for use in the oral cavity
HU0401177D0 (en)	2004-08-30	Pharmaceutical composition
GB2411355B (en)	2006-02-22	Pharmaceutical composition
EP1600445A4 (en)	2008-06-11	CURATIVE PREPARATION
GB0300885D0 (en)	2003-02-12	Pharmaceutical composition
GB0425255D0 (en)	2004-12-15	Pharmaceutical composition
ZA200701932B (en)	2008-08-27	Pharmaceutical composition
IL180316A0 (en)	2007-07-04	Quinolone-containing medicinal composition
IL177456A0 (en)	2006-12-10	Substituted azetidine compounds, their preparation and use as medicaments
EP1792620A4 (en)	2010-12-15	MEDICAL COMPOSITION WITH AN AGENT AGAINST DIABETES
ZA200701931B (en)	2008-10-29	Pharmaceutical composition